CoChat

C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins

Open access

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Abstract

Humans or mice subjected to immunosuppression, such as corticosteroids or anti-cytokine biologic therapies, are susceptible to mucosal infections by the commensal fungus Candida albicans. Recently it has become evident that the Th17/IL-17 axis is essential for immunity to candidiasis, but the downstream events that control immunity to this fungus are poorly understood. The CCAAT/Enhancer Binding Protein-β (C/EBPβ) transcription factor is important for signaling by multiple inflammatory stimuli, including IL-17. C/EBPβ is regulated in a variety of ways by IL-17, and controls several downstream IL-17 target genes. However, the role of C/EBPβ in vivo is poorly understood, in part because C/EBPβ-deficient mice are challenging to breed and work with. In this study, we sought to understand the role of C/EBPβ in the context of an IL-17-dependent immune response, using C. albicans infection as a model system. Confirming prior findings, we found that C/EBPβ is required for immunity to systemic candidiasis. In contrast, C/EBPβ(-/-) mice were resistant to oropharyngeal candidiasis (OPC), in a manner indistinguishable from immunocompetent WT mice. However, C/EBPβ(-/-) mice experienced more severe OPC than WT mice in the context of cortisone-induced immunosuppression. Expression of the antimicrobial peptide β-defensin (BD)-3 correlated strongly with susceptibility in C/EBPβ(-/-) mice, but no other IL-17-dependent genes were associated with susceptibility. Therefore, C/EBPβ contributes to immunity to mucosal candidiasis during cortisone immunosuppression in a manner linked to β-defensin 3 expression, but is apparently dispensable for the IL-17-dependent response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0136538

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 C/EBPβ-/- mice exhibit increased susceptibility to systemic candidiasis but are resistant to oral candidiasis. (A) The indicated mice (n = 3 per group) were injected with C. albicans in the lateral tail vein. Time to sacrifice is indicated (days). *P<0.05 versus (vs) C/EBPβ+/- mice using Log-rank (Mantel-Cox). (B) The indicated mice were infected sublingually with C. albicans for 75 mins. After 5 d, fungal loads in tongue were assessed by CFU enumeration of tongue tissue homogenates. Bars indicate geometric mean with 95% CI. C/EBPβ+/+ SHAM (n = 3), C/EBPβ+/+ (n = 5), C/EBPβ+/- (n = 9), C/EBPβ-/- (n = 3), C/EBPβ+/+ plus 225mg/kg cortisone (n = 3); cortisone acetate was administered by subcutaneous injection on days -1, +1 and +2 relative to infection. P<0.05 by t-test with Mann-Whitney correction: * vs C/EBPβ+/+ WT, ≠ vs C/EBPβ+/-, # vs C/EBPβ-/-, π vs C/EBPβ+/+ 225mg/kg. C. Weights of mice were assessed daily and graphed as percent of starting weight. * vs C/EBPβ+/+ WT. P<0.05 by t-test with Mann-Whitney correction. Experiment was performed once.
Fig 1 C/EBPβ-/- mice exhibit increased susceptibility to systemic candidiasis but are resistant to oral candidiasis. (A) The indicated mice (n = 3 per group) were injected with C. albicans in the lateral tail vein. Time to sacrifice is indicated (days). *P<0.05 versus (vs) C/EBPβ+/- mice using Log-rank (Mantel-Cox). (B) The indicated mice were infected sublingually with C. albicans for 75 mins. After 5 d, fungal loads in tongue were assessed by CFU enumeration of tongue tissue homogenates. Bars indicate geometric mean with 95% CI. C/EBPβ+/+ SHAM (n = 3), C/EBPβ+/+ (n = 5), C/EBPβ+/- (n = 9), C/EBPβ-/- (n = 3), C/EBPβ+/+ plus 225mg/kg cortisone (n = 3); cortisone acetate was administered by subcutaneous injection on days -1, +1 and +2 relative to infection. P<0.05 by t-test with Mann-Whitney correction: * vs C/EBPβ+/+ WT, ≠ vs C/EBPβ+/-, # vs C/EBPβ-/-, π vs C/EBPβ+/+ 225mg/kg. C. Weights of mice were assessed daily and graphed as percent of starting weight. * vs C/EBPβ+/+ WT. P<0.05 by t-test with Mann-Whitney correction. Experiment was performed once.CC BY · PubMed Central
Fig 2 C/EBPβ-/- mice exhibit increased susceptibility to oral candidiasis in the context of cortisone-induced immunosuppression. (A) C65BL/6 mice (“WT”) were treated with the indicated doses of cortisone acetate at days -1, +1 and +2 relative to infection. After 5 d, fungal loads in tongue were assessed by CFU enumeration of tongue tissue homogenates. SHAM (n = 3), No cortisone control (n = 5), 60mg/kg (n = 9), 120/112mg/kg (n = 8), and 225mg/kg (n = 8). Data are pooled from 2 independent experiments. Bars indicate geometric mean with 95% CI. P<0.05 by t-test with Mann-Whitney correction: * vs NO CORT, ≠ vs 60mg/kg, # vs 120/112mg/kg and π vs 225mg/kg. (B) The indicated mice were infected orally as described in panel A. Cortisone acetate was administered subcutaneously on days -1, +1 and +2 relative to infection. C/EBPβ+/+ SHAM (n = 3), C/EBPβ+/+ (n = 5), C/EBPβ+/+ 60 mg/kg (n = 16), C/EBPβ+/- 60mg/kg (n = 16), C/EBPβ-/- 60mg/kg (n = 10) and C/EBPβ+/+ 225mg/kg (n = 4). P<0.05 by t-test with Mann-Whitney correction: * vs C/EBPβ+/+ NO CORT, ≠ vs C/EBPβ+/+ 60mg/kg, # vs C/EBPβ+/- 60mg/kg and π vs C/EBPβ-/- 60mg/kg. Data are pooled from two independent experiments. C. Representative tongue sections from the indicated mice were stained with H&E or Periodic-acid Schiff (PAS). Scale bar indicates 200 μM. White arrows indicate hyphae.
Fig 2 C/EBPβ-/- mice exhibit increased susceptibility to oral candidiasis in the context of cortisone-induced immunosuppression. (A) C65BL/6 mice (“WT”) were treated with the indicated doses of cortisone acetate at days -1, +1 and +2 relative to infection. After 5 d, fungal loads in tongue were assessed by CFU enumeration of tongue tissue homogenates. SHAM (n = 3), No cortisone control (n = 5), 60mg/kg (n = 9), 120/112mg/kg (n = 8), and 225mg/kg (n = 8). Data are pooled from 2 independent experiments. Bars indicate geometric mean with 95% CI. P<0.05 by t-test with Mann-Whitney correction: * vs NO CORT, ≠ vs 60mg/kg, # vs 120/112mg/kg and π vs 225mg/kg. (B) The indicated mice were infected orally as described in panel A. Cortisone acetate was administered subcutaneously on days -1, +1 and +2 relative to infection. C/EBPβ+/+ SHAM (n = 3), C/EBPβ+/+ (n = 5), C/EBPβ+/+ 60 mg/kg (n = 16), C/EBPβ+/- 60mg/kg (n = 16), C/EBPβ-/- 60mg/kg (n = 10) and C/EBPβ+/+ 225mg/kg (n = 4). P<0.05 by t-test with Mann-Whitney correction: * vs C/EBPβ+/+ NO CORT, ≠ vs C/EBPβ+/+ 60mg/kg, # vs C/EBPβ+/- 60mg/kg and π vs C/EBPβ-/- 60mg/kg. Data are pooled from two independent experiments. C. Representative tongue sections from the indicated mice were stained with H&E or Periodic-acid Schiff (PAS). Scale bar indicates 200 μM. White arrows indicate hyphae.CC BY · PubMed Central
Fig 3 The susceptibility of C/EBPβ-/- mice to OPC does not correlate with expression of prototypical IL-17-regulated genes. mRNA from tongue was isolated from the indicated mice 5 days after oral C. albicans infection [C/EBPβ+/+ SHAM (n = 3), C/EBPβ+/+ NO CORT (n = 3), C/EBPβ+/+ 60mg/kg (n = 5), C/EBPβ+/- 60mg/kg (n = 6), and C/EBPβ-/- 60mg/kg (n = 5)]. Complementary DNA was prepared and subjected to qPCR analysis to detect the indicated genes. Results are presented as fold induction over SHAM treated mice and normalized to expression of Gapdh. Data are pooled from 2 independent experiments. P<0.05 by student unpaired t-test: * vs C/EBPβ+/+ NO CORT, ≠ vs C/EBPβ+/+ 60mg/kg, # vs C/EBPβ+/- 60mg/kg and π vs C/EBPβ-/- 60mg/kg.
Fig 3 The susceptibility of C/EBPβ-/- mice to OPC does not correlate with expression of prototypical IL-17-regulated genes. mRNA from tongue was isolated from the indicated mice 5 days after oral C. albicans infection [C/EBPβ+/+ SHAM (n = 3), C/EBPβ+/+ NO CORT (n = 3), C/EBPβ+/+ 60mg/kg (n = 5), C/EBPβ+/- 60mg/kg (n = 6), and C/EBPβ-/- 60mg/kg (n = 5)]. Complementary DNA was prepared and subjected to qPCR analysis to detect the indicated genes. Results are presented as fold induction over SHAM treated mice and normalized to expression of Gapdh. Data are pooled from 2 independent experiments. P<0.05 by student unpaired t-test: * vs C/EBPβ+/+ NO CORT, ≠ vs C/EBPβ+/+ 60mg/kg, # vs C/EBPβ+/- 60mg/kg and π vs C/EBPβ-/- 60mg/kg.CC BY · PubMed Central
Fig 4 Susceptibility of C/EBPβ-/- mice to OPC correlates with expression of BD3. (A) mRNA from tongue was isolated from the indicated mice 5 days after oral C. albicans infection [C/EBPβ+/+ SHAM (n = 3), C/EBPβ+/+ NO CORT (n = 3), C/EBPβ+/+ 60mg/kg (n = 5), C/EBPβ+/- 60mg/kg (n = 6), and C/EBPβ-/- 60mg/kg (n = 5)]. Complementary DNA was prepared and subjected to qPCR analysis to detect the indicated genes. Results are presented as fold induction over SHAM treated mice and normalized to expression of Gapdh. Data are pooled from two independent experiments. P<0.05 by student unpaired t-test. * vs C/EBPβ+/+ NO CORT, ≠ vs C/EBPβ+/+ 60mg/kg, # vs C/EBPβ+/- 60mg/kg and π vs C/EBPβ-/- 60mg/kg. (B) mRNA from tongue was isolated from the indicated mice 5 days after oral C. albicans infection and analyzed as in panel A. C/EBPβ+/+ SHAM (n = 3), C/EBPβ+/+ (n = 2), C/EBPβ+/- (n = 2), and C/EBPβ-/- (n = 2). Data are from one experiment. * P<0.05 by student unpaired t-test. vs C/EBPβ+/+, ≠ vs C/EBPβ+/- and π vs C/EBPβ-/-. (C) OKF6/TERT2 human oral keratinocytes were treated with 200 ng/ml IL-17 plus 2ng/ml TNFα or with 2×106 HK C. albicans for 24 h. Complementary DNA was prepared and subjected to qPCR analysis to detect DEFB4A. Data are normalized to expression of GAPDH and represent absolute levels. Data are representative of 2 independent experiments. *P<0.05 compared to unstimulated OKF6/TERT2 cells.
Fig 4 Susceptibility of C/EBPβ-/- mice to OPC correlates with expression of BD3. (A) mRNA from tongue was isolated from the indicated mice 5 days after oral C. albicans infection [C/EBPβ+/+ SHAM (n = 3), C/EBPβ+/+ NO CORT (n = 3), C/EBPβ+/+ 60mg/kg (n = 5), C/EBPβ+/- 60mg/kg (n = 6), and C/EBPβ-/- 60mg/kg (n = 5)]. Complementary DNA was prepared and subjected to qPCR analysis to detect the indicated genes. Results are presented as fold induction over SHAM treated mice and normalized to expression of Gapdh. Data are pooled from two independent experiments. P<0.05 by student unpaired t-test. * vs C/EBPβ+/+ NO CORT, ≠ vs C/EBPβ+/+ 60mg/kg, # vs C/EBPβ+/- 60mg/kg and π vs C/EBPβ-/- 60mg/kg. (B) mRNA from tongue was isolated from the indicated mice 5 days after oral C. albicans infection and analyzed as in panel A. C/EBPβ+/+ SHAM (n = 3), C/EBPβ+/+ (n = 2), C/EBPβ+/- (n = 2), and C/EBPβ-/- (n = 2). Data are from one experiment. * P<0.05 by student unpaired t-test. vs C/EBPβ+/+, ≠ vs C/EBPβ+/- and π vs C/EBPβ-/-. (C) OKF6/TERT2 human oral keratinocytes were treated with 200 ng/ml IL-17 plus 2ng/ml TNFα or with 2×106 HK C. albicans for 24 h. Complementary DNA was prepared and subjected to qPCR analysis to detect DEFB4A. Data are normalized to expression of GAPDH and represent absolute levels. Data are representative of 2 independent experiments. *P<0.05 compared to unstimulated OKF6/TERT2 cells.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 24

Metadata

Authors
Simpson-Abelson, M. R., Childs, E. E., Ferreira, M. C., Bishu, S., Conti, H. R., & Gaffen, S. L.
Affiliations
University of Pittsburgh (US)
Corresponding author
Gaffen, Sarah L.
Venue
PLoS ONE
Published
2015-08-28
Volume
10
Issue
8
Pages
e0136538
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1934986900
Cited by
24
References
53
Citations by year
2026: 1 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 2 · 2017: 3 · 2016: 3
FWCI
1.56
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Arthritis Foundation
  • Amgen
  • Eli Lilly and Company
  • Pfizer
  • University of Pittsburgh
  • National Institutes of Health (5r37de022550-12, DE022550)
  • National Institute of Allergy and Infectious Diseases (F32-AI098423, R01AI107825, F31AI098423, AI107825)
  • National Institute of Dental and Craniofacial Research (R37-DE022550, F32DE023293, R01DE022550, R01DE023815, DE022550, DE023815)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Keywords
C/EBPβ, oral candidiasis, Candida albicans, human beta-defensin 3, IL-17, Th17 cells, mucosal candidiasis, antimicrobial peptides, transcriptional regulation, systemic candidiasis
MeSH terms
Animals, Candida albicans, Candidiasis, Oral, Gene Expression Regulation, Mice, Knockout, Interleukin-17, CCAAT-Enhancer-Binding Protein-beta, beta-Defensins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins. https://app.cochat.ai/papers/10.1371/journal.pone.0136538
The paper
Simpson-Abelson, M. R., Childs, E. E., Ferreira, M. C., Bishu, S., Conti, H. R., & Gaffen, S. L. (2015). C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins. PLoS ONE. https://doi.org/10.1371/journal.pone.0136538

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.